CollPlant Biotechnologies (CLGN) Accumulated Depreciation & Amortization (2019 - 2024)
Historic Accumulated Depreciation & Amortization for CollPlant Biotechnologies (CLGN) over the last 6 years, with Q4 2024 value amounting to $7.0 million.
- CollPlant Biotechnologies' Accumulated Depreciation & Amortization rose 1617.6% to $7.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $7.0 million, marking a year-over-year increase of 1617.6%. This contributed to the annual value of $7.0 million for FY2024, which is 1617.6% up from last year.
- As of Q4 2024, CollPlant Biotechnologies' Accumulated Depreciation & Amortization stood at $7.0 million, which was up 1617.6% from $6.0 million recorded in Q4 2023.
- In the past 5 years, CollPlant Biotechnologies' Accumulated Depreciation & Amortization registered a high of $7.0 million during Q4 2024, and its lowest value of $660000.0 during Q4 2020.
- Over the past 5 years, CollPlant Biotechnologies' median Accumulated Depreciation & Amortization value was $1.0 million (recorded in 2022), while the average stood at $3.1 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first surged by 48359.07% in 2023, then soared by 1617.6% in 2024.
- Quarter analysis of 5 years shows CollPlant Biotechnologies' Accumulated Depreciation & Amortization stood at $660000.0 in 2020, then grew by 17.12% to $773000.0 in 2021, then skyrocketed by 34.02% to $1.0 million in 2022, then surged by 483.59% to $6.0 million in 2023, then grew by 16.18% to $7.0 million in 2024.
- Its Accumulated Depreciation & Amortization was $7.0 million in Q4 2024, compared to $6.0 million in Q4 2023 and $1.0 million in Q4 2022.